# Cebix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cebix

- Industry: Biotechnology
- Headquarters: US
- Website: www.cebix.com
- Total disclosed funding: $66M
- Latest round: Series B (Jan 29, 2014)
- Investors on record: 4

## About

Cebix Inc. is a bio-pharmaceutical company which engages in the development of chronic replacement therapy based on human pro-insulin C-peptide for the treatment of type 1 diabetic neuropathy.

## Funding rounds

- Series B, Jan 29, 2014, $4.1M — Sofinnova Investments, Thomas, McNerney & Partners
- Series B, Oct 17, 2012, $18M — InterWest Partners, Sofinnova Investments, Thomas, McNerney & Partners
- Series B, Sep 12, 2012, $13M — InterWest Partners, Sofinnova Investments, Thomas, McNerney & Partners
- Series A, Sep 24, 2009, $29M — InterWest Partners, Sofinnova Investments, Thomas, McNerney & Partners
- Series A, Oct 31, 2008, $2.9M — Sofinnova Investments, HealthCap

## Investors

- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B
- HealthCap — Series A
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series A, Series B
- Thomas, McNerney & Partners (https://capitalatlas.ai/funds/thomas-mcnerney-partners) — Series A, Series B